Details concerning the Ergocalciferol (Vitamin D2) combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ...

Benjamin Udoka Nwosu, Sadichchha Parajuli, Gabrielle Jasmin, Jody Fleshman, Rohit B. Sharma, Laura C. Alonso, Austin F. Lee, and Bruce A. Barton Journal of the Endocrine Society Share on Facebook.

Ergocalciferol 50,000 units per week and cholecalciferol 2,000 units per day can both correct 25-hydroxyvitamin D (25-OHD) deficiency within two months. Ergocalciferol recipients may achieve higher 25 ...

Results from a randomized, placebo-controlled study indicate that ergocalciferol is safe and effective in delaying the onset of secondary hyperparathyroidism in children with stage 2–3 chronic kidney ...

AUSTIN, Texas — A study presented at the National Kidney Foundation Spring Clinical Meetings showed ergocalciferol was as effective as cholecalciferol in maintaining vitamin D, parathyroid hormone and ...

(HealthDay News) — For patients on hemodialysis with serum 25-hydroxy vitamin D (25[OH]D) <30 ng/mL, ergocalciferol supplementation improves 25(OH)D levels but has no impact on epoetin utilization, ...

Associate Professor, Case Western Reserve University School of Medicine, Cleveland, Ohio; Clinical Specialist in Family Medicine, University Hospitals, Case Medical Center, Cleveland, Ohio ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

We have studied patients at the Baltimore City Hospitals and the Johns Hopkins Hospital who have required pharmacologic doses of vitamin D and had been maintained on calciferol for prolonged periods.

Newark, New Castle, USA, May 16, 2023 (GLOBE NEWSWIRE) -- Growth Plus Reports estimated the size of the global market for ergocalciferol in 2022 to be worth US$ 260 million, and it is expected that it ...

Quantum Pharma Plc (AIM: QP.), the growing, service-led niche pharmaceutical manufacturer, developer and supplier to the health and care sectors, is pleased to announce that Colonis Pharma Limited1 ...